Biologics

China sets ambitious biomedical goals with support of key companies

  The annual business revenue of the biomedical industry in Binhai is expected to reach 100 billion yuan ($15.44 billion) by 2025 with the ...

 October 01, 2021 | News

Cynata Enters into a New Strategic Partnership with Fujifilm

Cynata Therapeutics Limited (ASX: "CYP" or "Cynata"), a clinical-stage biotechnology company specialising in cell therapeutics, has today an...

 October 01, 2021 | News

Avantor Partnership will broaden global access for scientists

Partnership will broaden global access for scientists to benefit from portable DNA/RNA sequencing technology that provides rich data in real time, for life...

 September 28, 2021 | News

Invitae Highlights the Value of Genetic Testing

- Study finds improved seizure control and positive outcomes in 75 percent of patients with actionable genetic findings that led to clinical management cha...

 September 27, 2021 | News

GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target

GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio's sdAb targeting immune checkpoint target for disc...

 September 27, 2021 | News

Novavax and Serum Announce Submission to WHO for EU Listing of Novavax

  Novavax, Inc.  a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, w...

 September 24, 2021 | News

Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research

The Citeline Awards were created to recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its...

 September 24, 2021 | News

Everest Medicines to Advance mRNA Vaccines in Emerging Markets in Asia

Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...

 September 15, 2021 | News

J & J Ebola Vaccine booster shots showed strong immune responses

Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...

 September 14, 2021 | News

NeuExcell to reach the full potential of their innovative gene technology platform on accelerated timelines

FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell'...

 September 13, 2021 | News

Thermo Fisher Scientific to Further Expand Global Network of Single-Use Technology Manufacturing Sites

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashvil...

 September 10, 2021 | News

RMG-KB BIOACCESS FUND LAUNCHES with Worldwide Focus on Innovative Life Sciences Ventures

This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life scienc...

 September 08, 2021 | News

China to provide a best-in-class CAR-T therapy

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...

 September 07, 2021 | News

GenScript ProBio to Manufacture Innovative Antibody Drug

FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...

 September 06, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close